Summary

Friday, June 15, 2018

Name:
CANCER SEMINAR
Description:
PRMT5/PDGFRα axis: implications for cancer
Sara Calabretta, Postdoc Fellow
Dr. Stephane Richard’s Lab
&
Interferon-driven STAT1 activation sensitizes breast cancers to biguanides as anti-cancer agents
Stephanie Totten, M.D.,Ph.D.
Dr. Ursini Siegel’s Lab
Date:
Friday, June 15, 2018
Start Time:
12:00 PM
End Time:
01:00 PM
Venue:
BLOOMFIELD LECTURE HALL, F-4
Address:
3999, Chemin de la Côte-Ste-Catherine (corner of Legaré)
City:
Montreal
Province:
Quebec
 
Support research at the Lady Davis Institute - Jewish General Hospital